Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancer.
Jie ZhengYubo WangChen HuMengxiao ZhuJianghua IiCaiyu LinConghua LuYuanyao DouChenlong ZhaoYimin ZhangDi WuLi LiHuan TangTingting HeChunxiao PanRui HanYong HePublished in: Thoracic cancer (2022)
We based this study on ctDNA and cfDNA, explored its prognostic predictive ability, and combined CEA to monitor EGFR-TKI efficacy. This study may provide new perspectives and insights into the precise treatment strategies for NSCLC patients.